Expert explains everything you need to know about lutetium Lu-177 vipivotide tetraxetan for mCRPC
October 28th 2022"During treatment with 177Lu-PSMA-617, patients should be counseled to increase oral fluid intake and to void frequently to reduce bladder radiation exposure," writes Stephanie Trexler, PharmD, BCOP.